BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17218664)

  • 1. Automated multiple ligand screening by frontal affinity chromatography-mass spectrometry (FAC-MS).
    Ng W; Dai JR; Slon-Usakiewicz JJ; Redden PR; Pasternak A; Reid N
    J Biomol Screen; 2007 Mar; 12(2):167-74. PubMed ID: 17218664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary-scale frontal affinity chromatography/MALDI tandem mass spectrometry using protein-doped monolithic silica columns.
    Kovarik P; Hodgson RJ; Covey T; Brook MA; Brennan JD
    Anal Chem; 2005 May; 77(10):3340-50. PubMed ID: 15889927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
    Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
    Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of frontal affinity chromatography with mass spectrometry (FAC-MS) for stereospecific ligand-macromolecule interaction, detection and screening.
    Slon-Usakiewicz JJ; Redden P
    Methods Mol Biol; 2009; 572():219-30. PubMed ID: 20694695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery.
    Slon-Usakiewicz JJ; Ng W; Dai JR; Pasternak A; Redden PR
    Drug Discov Today; 2005 Mar; 10(6):409-16. PubMed ID: 15808820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination and identification of estrogenic compounds generated with biosynthetic enzymes using hyphenated screening assays, high resolution mass spectrometry and off-line NMR.
    de Vlieger JS; Kolkman AJ; Ampt KA; Commandeur JN; Vermeulen NP; Kool J; Wijmenga SS; Niessen WM; Irth H; Honing M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):667-74. PubMed ID: 20149764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal affinity chromatography coupled to mass spectrometry for screening mixtures of enzyme inhibitors.
    Zhang B; Palcic MM; Schriemer DC; Alvarez-Manilla G; Pierce M; Hindsgaul O
    Anal Biochem; 2001 Dec; 299(2):173-82. PubMed ID: 11730340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal affinity chromatography-mass spectrometry.
    Ng ES; Chan NW; Lewis DF; Hindsgaul O; Schriemer DC
    Nat Protoc; 2007; 2(8):1907-17. PubMed ID: 17703202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry.
    Calleri E; Temporini C; Caccialanza G; Massolini G
    ChemMedChem; 2009 Jun; 4(6):905-16. PubMed ID: 19378293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal affinity chromatography with MS detection of the ligand binding domain of PPARĪ³ receptor: ligand affinity screening and stereoselective ligand-macromolecule interaction.
    Calleri E; Fracchiolla G; Montanari R; Pochetti G; Lavecchia A; Loiodice F; Laghezza A; Piemontese L; Massolini G; Temporini C
    J Chromatogr A; 2012 Apr; 1232():84-92. PubMed ID: 22056242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA.
    Slon-Usakiewicz JJ; Ng W; Foster JE; Dai JR; Deretey E; Toledo-Sherman L; Redden PR; Pasternak A; Reid N
    J Med Chem; 2004 Oct; 47(21):5094-100. PubMed ID: 15456253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of protein-ligand interactions using dynamic protein-affinity chromatography solid-phase extraction-liquid chromatography-mass spectrometry.
    Jonker N; Kool J; Krabbe JG; Retra K; Lingeman H; Irth H
    J Chromatogr A; 2008 Sep; 1205(1-2):71-7. PubMed ID: 18715568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
    Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
    J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
    Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
    J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening.
    Toledo-Sherman L; Deretey E; Slon-Usakiewicz JJ; Ng W; Dai JR; Foster JE; Redden PR; Uger MD; Liao LC; Pasternak A; Reid N
    J Med Chem; 2005 May; 48(9):3221-30. PubMed ID: 15857128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
    Zhou JL; An JJ; Li P; Li HJ; Jiang Y; Cheng JF
    J Chromatogr A; 2009 Mar; 1216(12):2394-403. PubMed ID: 19203758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoproteome analysis of mouse liver using immobilized metal affinity purification and linear ion trap mass spectrometry.
    Jin WH; Dai J; Zhou H; Xia QC; Zou HF; Zeng R
    Rapid Commun Mass Spectrom; 2004; 18(18):2169-76. PubMed ID: 15378723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal affinity chromatography combined on-line with mass spectrometry: a tool for the binding study of different epidermal growth factor receptor inhibitors.
    Zhu L; Chen L; Luo H; Xu X
    Anal Chem; 2003 Dec; 75(23):6388-93. PubMed ID: 14640705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.